Xilio Therapeutics, Inc. (XLO)

NASDAQ: XLO · Real-Time Price · USD

0.5446

+0.0168 (3.18%)

At close: Mar 4, 2026, 4:00 PM EST

0.5499

+0.0053 (0.97%)

After-hours: Mar 4, 2026, 6:25 PM EST

Xilio Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	103.76	55.29	44.7	120.39	198.05	19.24
Cash & Short-Term Investments	103.76	55.29	44.7	120.39	198.05	19.24
Cash Growth	69.39%	23.68%	-62.87%	-39.22%	929.49%	-60.61%
Other Current Assets	20.33	4.94	3.42	4.11	4.46	1.35
Total Current Assets	124.09	60.23	48.13	124.5	202.52	20.59
Net Property, Plant & Equipment	7.8	9.06	11.07	12.84	13.6	13.68
Other Long-Term Assets	1.8	1.78	1.73	1.83	1.95	2.05
Total Assets	133.69	71.08	60.93	139.17	218.06	36.32
Accounts Payable	2.3	2.57	1.05	3.13	3.14	5.44
Accrued Expenses	8.95	9.98	10.5	10.33	8.75	13.73
Current Portion of Long-Term Debt	-	-	3.32	6.67	0.08	2.33
Current Portion of Leases	1.3	1.19	1.05	0.92	0.8	0.56
Unearned Revenue	43.85	13.52	-	-	-	-
Other Current Liabilities	-	-	0.05	0.08	12.78	0.08
Total Current Liabilities	56.4	27.26	15.96	21.12	12.78	22.16
Long-Term Debt	-	-	-	3.17	9.63	7.41
Long-Term Leases	5.96	6.95	8.14	9.19	10.11	10.91
Other Long-Term Liabilities	79.43	19.26	-	0.05	0.12	1.13
Total Long-Term Liabilities	85.39	26.22	8.14	12.4	19.85	19.45
Total Liabilities	141.79	53.48	24.1	33.52	32.63	41.6
Common Stock	0.01	0.01	0	0	0	-
Additional Paid-in Capital	421.05	401.35	362.34	354.75	346.31	1.8
Retained Earnings	-429.15	-383.75	-325.51	-249.11	-160.89	-85.09
Total Common Shareholders' Equity	-8.1	17.6	36.83	105.65	185.43	-83.29
Minority Interest	-	-	-	-	-	78
Shareholders' Equity	-8.1	17.6	36.83	105.65	185.43	-5.29
Total Liabilities & Equity	133.69	71.08	60.93	139.17	218.06	36.32
Total Debt	7.26	8.14	12.5	19.94	20.62	21.22
Net Cash (Debt)	96.5	47.15	32.2	100.45	177.44	-1.98
Net Cash Growth	104.67%	46.42%	-67.94%	-43.39%	-	-
Net Cash Per Share	1.02	0.88	1.17	3.67	31.65	-3.78
Book Value	-8.1	17.6	36.83	105.65	185.43	-83.29
Book Value Per Share	-0.09	0.33	1.34	3.86	33.08	-159.01
Tangible Book Value	-8.1	17.6	36.83	105.65	185.43	-83.29
Tangible Book Value Per Share	-0.09	0.33	1.34	3.86	33.08	-159.01

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q